Dr Nicolas Brandes
Director Business Development & Sales

Is this your profile?

About

Nicolas Brandes, PhD, has been Director Business Development & Sales at ten23 health since March 2024. Prior to ten23, Dr Brandes spent 15 years at West Pharmaceutical Services in Business Development, Product Management and R&D, working on integrated packaging containment and drug delivery systems. Dr Brandes studied Biology at the University of Wuerzburg (Germany) and the Universidad de Salamanca (Spain), and holds a PhD in Biochemistry from the University of Michigan (Ann Arbor, MI, US).

Contributions

DEVICE SELECTION: INJECTION VOLUMES FOR SUBCUTANEOUS ADMINISTRATION

Nicolas Brandes, Andrea Allmendinger and Hanns-Christian Mahler explore the critical considerations for subcutaneous injection volume, beginning with the historical and scientific perspectives on injection volume before delving into the challenges of determining volume ranges and their associated fill volumes.

More contributions

CONNECTED HEALTH: THE FUTURE OF EFFECTIVE DRUG DELIVERY

Chris Evans and Nicolas Brandes both of West, set the company's movement into connected health in the context of trends in the pharmaceutical industry. They introduce their partnership with HealthPrize.

DRUG PACKAGING SYSTEMS FOR THE DIGITAL HEALTH ERA

Nicolas Brandes discusses how the SmartDose high-volume injection device blends together a primary containment materials, the delivery device and a smartphone app from HealthPrize.

PREFILLED SYRINGES

FOUR WAYS POLYMERS TRUMP GLASS FOR CONTAINING CUTTING-EDGE INJECTABLE BIOLOGICS

Nicolas Brandes makes the case that polymers offer superior benefits compared with glass as a material for primary containers and delivery systems for parenteral drugs, including in particular biologics.

Top